Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Carotid Artery Disease: later-stage trial registry
1 of 6 indexed Carotid Artery Disease trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 1 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Carotid Artery Disease: 6 US clinical trials tracked, 1 recruiting.
Carotid Artery Disease is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Medtronic Endovascular, running 2 of these trials.
Enrollment posture brief
Registry condition carotid-artery-disease
OPEN 1 | RECR 17% | LATE 1 | EARLY 0 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)
Carotid Artery Disease lists 1 open slots (17% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Carotid Artery Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Carotid Artery Disease is recruiting below its size-band peers.
1 of 6 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Carotid Artery Disease research.
Medtronic Endovascular accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Carotid Artery Disease enrolment sits around 1,500 participants.
Median target enrolment is 1,500 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.
-
Carotid Artery Disease splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
SVS VQI TransCarotid Revascularization Surveillance Project
Society for Vascular Surgery Patient Safety Organization
NCT02850588
CAPTURE 2 Post-Marketing Registry
Abbott Medical Devices
NCT00302237
Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study
Medtronic Endovascular
NCT00530504
Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial
Medtronic Endovascular
NCT00619775
The Gore SCAFFOLD Clinical Study
W.L.Gore & Associates
NCT01901874
Assessment Of Vascular Health After Niacin Therapy (AVANT)
University of Pennsylvania
NCT02003638
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Carotid Artery Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Carotid Artery Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Carotid Artery Disease page
6 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Carotid Artery Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Medtronic Endovascular sponsors the most Carotid Artery Disease trials on record, review their full trial history before evaluating a specific study. See Medtronic Endovascular's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Carotid Artery Disease condition card totals 6 registered trials; most-linked intervention PROTÉGÉ® GPS™ and PROTÉGÉ® RX Carotid Stent Systems and Spider Embolic Protection Device; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.